Sobi (Swedish Orphan Biovitrum AB)
(https://synagis.com) 📸 Data Snapshot: June 19, 2026Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
The site avoids common trust theatre traps like unverified reviews or generic award badges (review_count is 0). It relies on ‘Institutional Proof’ including a Swedish corporate registration number (556038-9321) and specific humanitarian partnership mentions (WFH Humanitarian Aid Program), though many bold claims about ‘meaningful progress’ in sustainability lack direct external evidence links in this view.
Proof points are concentrated in regulatory and event-based data rather than customer testimonials. The ratio favors substance due to the mention of specific upcoming medical congresses (EHA 2026, ERA 2026) and a defined R&D pipeline context, even if the sub-page content in this crawl is repetitive.
Trust & Proof is read by weighing trust language against real verification. Below is the page-by-page tally of review mentions and external proof links, then the schema markup that may (or may not) declare verifiable ratings and identity proof.
🛡️ Trust Signals — reviews, proof links, trust-theatre check
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
| /middle-east/en/ | 0 | 0 |
| /en/pipeline/ | 0 | 0 |
| /en/careers/ | 0 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: declared ratings, reviews & identity proof
Homepage schema
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "Organization",
"additionalType": "MedicalOrganization",
"@id": "https://www.sobi.com/",
"description": "Sobi is an international biopharmaceutical company focused on rare diseases.",
"name": "Sobi",
"sameAs": [
"https://en.wikipedia.org/wiki/Swedish_Orphan_Biovitrum",
"https://www.linkedin.com/company/sobi/",
"https://www.youtube.com/c/Sobi-Pharma"
],
"url": "https://www.sobi.com/",
"telephone": "+4686972000",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+4686972000",
"email": "info@sobi.com",
"url": "https://www.sobi.com/",
"availableLanguage": [
"English",
"Swedish"
]
},
"image": {
"@type": "ImageObject",
"url": "https://www.sobi.com/sites/sobi/files/styles/banner/public/images/young-kid-leaves.jpg.webp?itok=DwHwUQ3X"
},
"logo": {
"@type": "ImageObject",
"representativeOfPage": "True",
"url": "https://www.sobi.com/themes/sobi/img/logo.svg",
"width": "284",
"height": "108"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "Box",
"addressLocality": "Stockholm",
"postalCode": "SE-112 76",
"addressCountry": "Sweden"
}
}
]
}
/middle-east/en/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "Organization",
"additionalType": "MedicalOrganization",
"@id": "https://www.sobi.com/",
"description": "Sobi is an international biopharmaceutical company focused on rare diseases.",
"name": "Sobi",
"sameAs": [
"https://en.wikipedia.org/wiki/Swedish_Orphan_Biovitrum",
"https://www.linkedin.com/company/sobi/",
"https://www.youtube.com/c/Sobi-Pharma"
],
"url": "https://www.sobi.com/",
"telephone": "+4686972000",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+4686972000",
"email": "info@sobi.com",
"url": "https://www.sobi.com/",
"availableLanguage": [
"English",
"Swedish"
]
},
"image": {
"@type": "ImageObject",
"url": "https://www.sobi.com/sites/sobi/files/styles/banner/public/images/young-kid-leaves.jpg.webp?itok=DwHwUQ3X"
},
"logo": {
"@type": "ImageObject",
"representativeOfPage": "True",
"url": "https://www.sobi.com/themes/sobi/img/logo.svg",
"width": "284",
"height": "108"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "Box",
"addressLocality": "Stockholm",
"postalCode": "SE-112 76",
"addressCountry": "Sweden"
}
}
]
}
/en/pipeline/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "Organization",
"additionalType": "MedicalOrganization",
"@id": "https://www.sobi.com/",
"description": "Sobi is an international biopharmaceutical company focused on rare diseases.",
"name": "Sobi",
"sameAs": [
"https://en.wikipedia.org/wiki/Swedish_Orphan_Biovitrum",
"https://www.linkedin.com/company/sobi/",
"https://www.youtube.com/c/Sobi-Pharma"
],
"url": "https://www.sobi.com/",
"telephone": "+4686972000",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+4686972000",
"email": "info@sobi.com",
"url": "https://www.sobi.com/",
"availableLanguage": [
"English",
"Swedish"
]
},
"image": {
"@type": "ImageObject",
"url": "https://www.sobi.com/sites/sobi/files/styles/banner/public/images/young-kid-leaves.jpg.webp?itok=DwHwUQ3X"
},
"logo": {
"@type": "ImageObject",
"representativeOfPage": "True",
"url": "https://www.sobi.com/themes/sobi/img/logo.svg",
"width": "284",
"height": "108"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "Box",
"addressLocality": "Stockholm",
"postalCode": "SE-112 76",
"addressCountry": "Sweden"
}
}
]
}
/en/careers/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "Organization",
"additionalType": "MedicalOrganization",
"@id": "https://www.sobi.com/",
"description": "Sobi is an international biopharmaceutical company focused on rare diseases.",
"name": "Sobi",
"sameAs": [
"https://en.wikipedia.org/wiki/Swedish_Orphan_Biovitrum",
"https://www.linkedin.com/company/sobi/",
"https://www.youtube.com/c/Sobi-Pharma"
],
"url": "https://www.sobi.com/",
"telephone": "+4686972000",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+4686972000",
"email": "info@sobi.com",
"url": "https://www.sobi.com/",
"availableLanguage": [
"English",
"Swedish"
]
},
"image": {
"@type": "ImageObject",
"url": "https://www.sobi.com/sites/sobi/files/styles/banner/public/images/young-kid-leaves.jpg.webp?itok=DwHwUQ3X"
},
"logo": {
"@type": "ImageObject",
"representativeOfPage": "True",
"url": "https://www.sobi.com/themes/sobi/img/logo.svg",
"width": "284",
"height": "108"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "Box",
"addressLocality": "Stockholm",
"postalCode": "SE-112 76",
"addressCountry": "Sweden"
}
}
]
}
This page presents a snapshot of public data from Sobi (Swedish Orphan Biovitrum AB), captured on June 19, 2026, to show how machine logic reads Trust & Proof signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Sobi (Swedish Orphan Biovitrum AB): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://synagis.com to view the most current version of its content and see directly what this company is about and what it offers.